Brodsky M A, Orlov M V, Allen B J, Orlov Y S, Wolff L, Winters R
Department of Medicine, University of California Irvine Medical Center, Orange 92668-3298, USA.
Am Heart J. 1996 Jan;131(1):51-8. doi: 10.1016/s0002-8703(96)90050-2.
To further define the relation between changing adrenergic tone, beta-blocker therapy, and clinical ventricular tachycardia (VT), we evaluated these factors in 35 patients with VT unrelated to coronary artery disease or ventricular dysfunction. Testing included Holter monitoring (91% had VT), exercise test (69% had VT), Adrenergic responsiveness of VT was graded according to diurnal variation, response to exercise, isoproterenol infusion, and response to beta-blockers. beta-Blockers were effective and well tolerated in this population. There was also a predictable relation between changing adrenergic tone and the arrhythmia response to beta-blocker therapy.
为了进一步明确肾上腺素能张力变化、β受体阻滞剂治疗与临床室性心动过速(VT)之间的关系,我们对35例与冠状动脉疾病或心室功能障碍无关的室性心动过速患者的这些因素进行了评估。检测包括动态心电图监测(91%有室性心动过速)、运动试验(69%有室性心动过速),根据昼夜变化、对运动的反应、异丙肾上腺素输注以及对β受体阻滞剂的反应对室性心动过速的肾上腺素能反应性进行分级。β受体阻滞剂在该人群中有效且耐受性良好。肾上腺素能张力变化与β受体阻滞剂治疗的心律失常反应之间也存在可预测的关系。